36501
-
Upload
geneticslab -
Category
Documents
-
view
219 -
download
0
Transcript of 36501
-
8/13/2019 36501
1/28
A novel source for Mesenchymal stem cells
Jayanti Tokas1, Deepika Gupta1, Divya Pasrija1, Rubina Begum1, Shalini Jain2and Hariom
Yadav2
1Department of Biotechnology, JMIT, Radaur, Haryana, India
2NIDDK, National Institutes of Health, Bethesda, MD 20892, USA
Corresponding: [email protected]
-
8/13/2019 36501
2/28
FETAL STEM CELLS
Sources
Specific fetal tissues
Fetal circulation, placenta, Amniotic fluid
Umbilical cord
Potentiality varies from pluripotent to multipotent.
-
8/13/2019 36501
3/28
Fetal stem cells
Hemopoietic stem cells (HSC)
Mesenchymal stem cells (MSC)
First-trimester blood
richer source of HSC and MSC
Greater proliferative capacity
wider differentiation ability
Can be clonally derived.
FETAL STEM CELLS
-
8/13/2019 36501
4/28
AMNIOTIC FLUID
Clear, yellowish liquid, surrounds the fetus during
pregnancy
Continuously inhaled, exhaled and urinated by the
baby.
It is 98% water and electrolytes, proteins, peptides,carbohydrates, lipids and hormones.
-
8/13/2019 36501
5/28
Protects the developing baby against blows to the
mother's abdomen
Allows easier fetal movement
Promotes muscular/skeletal development
Protect the fetus from heat loss.
Plays a significant defensive role
AMNIOTIC FLUID
-
8/13/2019 36501
6/28
Amniotic
fluid
-
8/13/2019 36501
7/28
ROLE IN FETAL DEVELOPMENT
Contains nutritional components such as proteins,
glucose, triglyceride and cholesterol
proteins and peptides possess potent bioactivity
Growth factors in AF are transported throughout
fetal body
Helps cellular movement, organs development,
cellular growth and proliferation.
-
8/13/2019 36501
8/28
AMNIOTIC FLUID STEM CELLS
Potentiality varies from pluripotent to multipotent
Second and third trimester amniotic fluid is major source
Allow scientists to sidestep the controversy over
destroying embryos for research
Can be used for tissue repair and engineering organs
Mesenchymal stem cells quantity is high in amniotic fluid
-
8/13/2019 36501
9/28
HETEROGENEITY OF AMNIOTIC FLUID
Variation in
Shape
Size
Nuclear/ cytoplasmic ratio
Cytoplasmic characteristics
Cell surface properties
Biochemical properties
Some cells express markers of glial and neuronal
stem cells.
-
8/13/2019 36501
10/28
AMNIOTIC FLUID :NEW SOURCE FOR
NEURAL STEM CELLS
Amniotic fluid cells when incubated with neurogenic
medium express
CD133
Nestin
Neurofilament
CNPase
p75
Neurotrophin receptor (the brain-derived neurotrophic factor and
neurotrophin-3)
Human amniotic fluid contains cells that express markers for neuronal
stem and progenitor cells, which harbour the potential to differentiate
into neurogenic cells
-
8/13/2019 36501
11/28
MESENCHYMAL STEM CELLS
Morphology
Small cell body with a few cell processes
Large and round nucleus with a prominent
nucleolus
A small amount of
Golgi apparatus
Rough endoplasmic reticulum Mitochondria
Polyribosomes .
-
8/13/2019 36501
12/28
Detection Surface antigens
Differentiation capacity
Multipotent-Can differentiate into Osteoblasts
Adipocytes
chondrocytes
myocytes
neuron-like cells.
Differentiation capacity decreases with the age ofthe donor and the time in culture
MESENCHYMAL STEM CELLS
-
8/13/2019 36501
13/28
MESENCHYMAL STEM CELLS AND ITS
DIFFERENTIATION CAPACITY
-
8/13/2019 36501
14/28
ISOLATION AND CULTURE
Sterile needle is inserted through the abdominal wall into the
amniotic sac
Small amount of amniotic fluid is withdrawn through needle
Amniotic fluid contains fetal cells which are separated from
amniotic fluid
Cultured
Tests are performed on cultured cells
Chemical analysis
DNA analysis
Chromosomal Analysis
-
8/13/2019 36501
15/28
MESENCHYMAL STEM CELLS : FIRSTTRIMESTER
CD291 CD441
SH21
SH31
SH41
prolyl-4-hydroxylase
Actin
CD452
CD342
CD142
CD682
Vwf2
HLA-DR2
Fibronectin
Laminin
Vimentin
In undifferentiated state, fetal blood, liver and bone marrow
MSCs express
-
8/13/2019 36501
16/28
MSCs differentiate into
Adipocytes
Osteocytes
Chondrocytes.
Provide novel targets for in utero cellular
and gene therapy.
MESENCHYMAL STEM CELLS : FIRSTTRIMESTER
-
8/13/2019 36501
17/28
MSCs exhibit a phenotype and multilineage
differentiation potential similar to postnatal bone
marrow (BM)derived MSCs .
Multipotent (CD29)
Pluripotent (Oct-4)
MESENCHYMAL STEM CELLS : SECONDTRIMESTER
-
8/13/2019 36501
18/28
Express Oct-4.
Samples can be collected in larger amount than the second
trimester, with a much lower risk of uterine contamination.
High renewal capacity and therapeutic applications.
Share same properties and differentiation capabilities as human
embryonic stem cells .
Differ from embryonic stem cells in promising ways :
1. Do not produce teratomas when transplanted into animals.
2. Low antigenicity is an advantage for cell transplantation or cell replacement
therapy.
MESENCHYMAL STEM CELLS : THIRDTRIMESTER
-
8/13/2019 36501
19/28
PRESERVATION
Vitrification
Amniotic stem cell banks
-
8/13/2019 36501
20/28
VITRIFICATION
-
8/13/2019 36501
21/28
AMNIOTIC STEM CELL BANKS
Biocell center, European biotechnology company is
the first firm to harvest and preserve amniotic stem
cells
Biocell Center captures the stem cells from amniotic
fluid if the family requests and pays for the
preservation of the stem cells
Amniotic fluid withdrawn during amniocentesis is
sent to the Biocell Center laboratory. The stem cells
are frozen in liquid nitrogen and preserved in the
company's state-of-the-art cryo-bank.
-
8/13/2019 36501
22/28
H.R. 1892National Amniotic and Placental
Stem Cell Bank of 2007
The bill shows the importance of amniotic stem cells bankwhich would
Establish a National Amniotic and Placental Stem Cell Bank for
the purpose of obtaining, storing, and making available for
research and treatment human stem cells derived from
amniotic fluid or placenta .
Will maintain a collection of at least 100,000 samples of stem
cells in order to ensure genetic diversity
Will obtain stem cells only if informed consent is provided
-
8/13/2019 36501
23/28
REGENERATIVEMEDICINE
As regenerative medicine amniotic fluid stem cells
has many applications .
Cultured MSCs have been transplanted in childrenwith osteogenesis imperfecta (OI), a disease
causing bone fractures and fragility.
Reduced bone fractures and increased bone
density were reported to be found when MSCs were
engrafted into the defective bone
-
8/13/2019 36501
24/28
MYOCARDIAL INFARCTION
MSCs can be engrafted at the damaged
site(s), attenuate pathologic remodeling of
the heart tissue and reduce scar size,
leading to improved post-MI cardiac
function
-
8/13/2019 36501
25/28
ETHICAL ASPECTS
Amniotic fluid solve a lot of problems
It's possible to catch amniotic stem cells without
destroying embryos
They are not necessary to choose an alternative
between donor or autologuous use
-
8/13/2019 36501
26/28
NEXT STEPS TO DO
For the future it is of great importance to obtain more insights into the
spectrum of cells contained in human amniotic fluid.
Using RT-PCR the expression of a wide variety of genes, known as
markers for stem cells, progenitor cells and differentiated cell types,should be analysed.
Amniotic fluid contains Oct-4 positive cells, a major issue for the
future is to investigate the differentiation potential of the Oct-4
positive amniotic fluid cells
It is essential to think about strategies to isolate/enrich Oct-4 positive
cells out of amniotic fluid.
-
8/13/2019 36501
27/28
It is an ocean full of
pearls and we need to
search these pearls only
for our benefit.
-
8/13/2019 36501
28/28